Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials

Munya Dimairo; Jonathan Boote; Steven A. Julious; Jon Nicholl; Susan Todd

doi:10.1186/s13063-015-0958-9

Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials

Munya Dimairo, Jonathan Boote, Steven A. Julious, Jon Nicholl, Susan Todd

Research output: Contribution to journal › Article › peer-review

25 Citations (Scopus)

90 Downloads (Pure)

Abstract

Despite the promising benefits of adaptive designs (ADs), their routine use, especially in confirmatory trials, is lagging behind the prominence given to them in the statistical literature. Much of the previous research to understand barriers and potential facilitators to the use of ADs has been driven from a pharmaceutical drug
development perspective, with little focus on trials in the public sector. In this paper, we explore key stakeholders’ experiences, perceptions and views on barriers and facilitators to the use of ADs in publicly funded confirmatory trials

Original language	English
Article number	430
Number of pages	16
Journal	Trials
Volume	16
DOIs	https://doi.org/10.1186/s13063-015-0958-9
Publication status	Published - 28 Sept 2015

Access to Document

10.1186/s13063-015-0958-9

907170
© 2015 Dimairo et al. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated
Final published version, 633 KB

Cite this

@article{568967ae9dd74c4cbe07869d5cfe2537,

title = "Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials",

abstract = "Despite the promising benefits of adaptive designs (ADs), their routine use, especially in confirmatory trials, is lagging behind the prominence given to them in the statistical literature. Much of the previous research to understand barriers and potential facilitators to the use of ADs has been driven from a pharmaceutical drugdevelopment perspective, with little focus on trials in the public sector. In this paper, we explore key stakeholders{\textquoteright} experiences, perceptions and views on barriers and facilitators to the use of ADs in publicly funded confirmatory trials",

author = "Munya Dimairo and Jonathan Boote and Julious, {Steven A.} and Jon Nicholl and Susan Todd",

note = "Date of Acceptance: 14/09/2015. {\textcopyright} 2015 Dimairo et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated",

year = "2015",

month = sep,

day = "28",

doi = "10.1186/s13063-015-0958-9",

language = "English",

volume = "16",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central (BMC)",

}

TY - JOUR

T1 - Missing steps in a staircase

T2 - a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials

AU - Dimairo, Munya

AU - Boote, Jonathan

AU - Julious, Steven A.

AU - Nicholl, Jon

AU - Todd, Susan

N1 - Date of Acceptance: 14/09/2015. © 2015 Dimairo et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated

PY - 2015/9/28

Y1 - 2015/9/28

N2 - Despite the promising benefits of adaptive designs (ADs), their routine use, especially in confirmatory trials, is lagging behind the prominence given to them in the statistical literature. Much of the previous research to understand barriers and potential facilitators to the use of ADs has been driven from a pharmaceutical drugdevelopment perspective, with little focus on trials in the public sector. In this paper, we explore key stakeholders’ experiences, perceptions and views on barriers and facilitators to the use of ADs in publicly funded confirmatory trials

AB - Despite the promising benefits of adaptive designs (ADs), their routine use, especially in confirmatory trials, is lagging behind the prominence given to them in the statistical literature. Much of the previous research to understand barriers and potential facilitators to the use of ADs has been driven from a pharmaceutical drugdevelopment perspective, with little focus on trials in the public sector. In this paper, we explore key stakeholders’ experiences, perceptions and views on barriers and facilitators to the use of ADs in publicly funded confirmatory trials

U2 - 10.1186/s13063-015-0958-9

DO - 10.1186/s13063-015-0958-9

M3 - Article

SN - 1745-6215

VL - 16

JO - Trials

JF - Trials

M1 - 430

ER -

Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials

Abstract

Access to Document

Fingerprint

Cite this